Phyto Chem India Ltd (524808)
Latest quarterly results (Q4 FY26)
In its latest reported quarter, Q4 FY26, Phyto Chem's revenue was ₹0.2 Cr (-84.2% year on year, -92.3% on the previous quarter), and net profit ₹-0.3 Cr (a smaller loss than a year earlier); the operating margin was -287.0%.
| Q4 FY26 (₹ Cr) | Value | YoY vs Q4 FY25 | QoQ |
|---|---|---|---|
| Revenue | ₹0.2 | -84.2% | -92.3% |
| Operating profit | ₹-0.7 | loss narrowed | loss widened |
| Net profit | ₹-0.3 | loss narrowed | loss narrowed |
| EPS (₹) | -0.65 | loss narrowed | loss narrowed |
| Operating margin | -287.0% | — | — |
📢 Recent Corporate Announcements
Phyto Chem (India) Limited held a meeting of its Board of Directors on September 29, 2026. The Board reviewed the business and performance of the company, which generated TTM revenue of Rs 9.06 Cr and posted a net loss of Rs 1.8 Cr in FY26. The company stated that no material events requiring disclosure under Regulation 30 were considered or approved during the meeting. The meeting concluded in 40 minutes, starting at 11:30 A.M. and finishing at 12:10 P.M.
- Board meeting conducted on 29th September 2026
- Meeting commenced at 11:30 A.M. and concluded at 12:10 P.M.
- Board reviewed company business and performance
- No material events requiring disclosure under Regulation 30 were approved
Phyto Chem (India) Limited has notified exchanges regarding the closure of its Register of Members and Share Transfer Books from September 23, 2026, to September 29, 2026 (both days inclusive). The book closure is set for the purpose of conducting the company's 37th Annual General Meeting. This is a standard statutory notification pursuant to Section 91 of the Companies Act, 2013, and Regulation 42 of SEBI LODR Regulations, with no impact on underlying business operations.
- Book closure scheduled from 23rd September 2026 to 29th September 2026 (both days inclusive)
- Closure purpose: 37th Annual General Meeting
- Complies with Section 91 of Companies Act, 2013 and Regulation 42 of SEBI LODR Regulations
Phyto Chem India reported a severe operational downturn in Q1 FY27, with revenue from operations plummeting 98.3% YoY to just ₹2.54 Lakhs. The net loss nearly doubled to ₹90.47 Lakhs from ₹48.45 Lakhs in the same period last year. A critical concern is the finance cost of ₹35.92 Lakhs, which is more than 14 times the quarterly revenue, indicating a severe debt-servicing burden. With a market cap of only ₹9 Cr and debt of ₹20 Cr, the company's financial position appears increasingly precarious.
- Revenue from operations fell to ₹2.54 Lakhs from ₹150.32 Lakhs in the year-ago quarter.
- Net loss widened to ₹90.47 Lakhs compared to a loss of ₹48.45 Lakhs in June 2025.
- Finance costs remained high at ₹35.92 Lakhs, significantly exceeding total income of ₹6.08 Lakhs.
- Total expenses of ₹99.47 Lakhs were incurred despite the near-total cessation of revenue-generating activities.
- Basic and Diluted EPS worsened to ₹-2.10 from ₹-1.13 YoY.
Phyto Chem India has approved leasing out 32,420 sq ft of its manufacturing facility at Bonthapally to Tricom Agro Private Limited for a 3-year term. The estimated monthly rental is Rs 9,00,000, totaling Rs 1.08 crore annually, which represents approximately 12% of the company's TTM revenue of Rs 9 crore. This strategic move aims to utilize spare capacity in a challenging pesticide market environment. For a company with a TTM PAT of Rs -2 crore and high debt (D/E 4.48), this steady rental income provides a significant liquidity cushion.
- Monthly lease rental income estimated at approximately Rs 9,00,000 (Rs 1.08 Cr annually)
- Leasing 32,420 sq ft out of a total constructed area of 50,750 sq ft
- Lease tenure fixed for 3 years with periodic escalation clauses
- Assets leased include 5.15 acres of land and plant machinery such as mixing tanks and granule mixers
- Transaction is with an independent third party, not a related party
Phyto Chem India Ltd has scheduled a board meeting for August 13, 2026, to approve its unaudited financial results for the quarter ended June 30, 2026. The company is currently in a precarious financial position with a TTM revenue of Rs 9 Cr and a net loss of Rs 2 Cr. With a high debt-to-equity ratio of 4.48 and negative operating margins of -20.6%, these results are critical for assessing the company's ongoing viability. The trading window for insiders has been closed since July 1, 2026.
- Board meeting scheduled for August 13, 2026, at 03:30 P.M. to review Q1 results.
- Trading window closed from July 1, 2026, until 48 hours after the results announcement.
- Company reported a significant revenue drop to Rs 0.23 Cr in the March 2026 quarter.
- Total debt stands at Rs 20 Cr against a small net worth of Rs 5 Cr.
- FY26 annual revenue declined to Rs 9.07 Cr from Rs 14.08 Cr in FY25.
Financial Performance
Financial analysis data not yet available for this company.
Operational Drivers
Operational analysis data not yet available for this company.
Strategic Growth
Strategic growth analysis not yet available for this company.
External Factors
External factors analysis not yet available for this company.
Regulatory & Governance
Regulatory analysis not yet available for this company.
Risk Analysis
Risk analysis not yet available for this company.
